Current through Bulletin 2024-24, December 15, 2024
Section R590-261-3 - DefinitionsTerms used in this rule are defined in Section 31A-1-301 and 45 CFR 147.140. Additional terms are defined as follows:
(1)(a) "Adverse benefit determination" means:(i) based on the carrier's requirements for medical necessity, appropriateness, health care setting, level of care, or effectiveness of a covered benefit, the: (B) reduction of a benefit;(C) termination of a benefit; or(D) failure to provide or make payment, in whole or part, for a benefit; or(ii) rescission of coverage.(b) "Adverse benefit determination" includes:(i) denial, reduction, termination, or failure to provide or make payment that is based on a determination of an insured's eligibility to participate in a health benefit plan;(ii) failure to provide or make payment, in whole or part, for a benefit resulting from the application of a utilization review; and(iii) failure to cover an item or service for which benefits are otherwise provided because it is determined to be:(C) not medically necessary or appropriate.(2) "Authorized representative" means: (a) a person to whom an insured has given express written consent for representation in an external review;(b) a person authorized by law to provide substituted consent for an insured; or(c) when the insured is unable to provide consent: (i) a family member of the insured; or(ii) the insured's treating health care provider.(3) "Carrier" means a person that provides health insurance in this state including:(a) an insurance company;(b) a prepaid hospital or medical care plan;(c) a health maintenance organization;(d) a multiple employer welfare arrangement; and(e) any other person providing a health insurance plan under Title 31A, Insurance Code.(4) "Claimant" means the insured or the insured's authorized representative.(5) "Clinical reviewer" means a physician or other appropriate health care provider who: (a) is an expert in the treatment of the medical condition that is the subject of the review;(b) is knowledgeable about the recommended health care service or treatment through recent or current actual clinical experience treating patients with the same or similar medical condition;(c) holds an appropriate license or certification; and(d) has no history of disciplinary actions or sanctions. (6) "Final adverse benefit determination" means an adverse benefit determination that has been upheld by a carrier at the completion of the carrier's internal review process.(7) "Independent review" means a process that:(a) is a voluntary option for the resolution of a final adverse benefit determination;(b) is conducted at the discretion of the claimant;(c) is conducted by an independent review organization designated by the commissioner;(d) renders an independent and impartial decision on a final adverse benefit determination; and(e) may not require the claimant to pay a fee for requesting the independent review.(8)(a) "Rescission" means a cancellation or discontinuance of coverage under a health benefit plan that has a retroactive effect.(b) "Rescission" does not include a cancellation or discontinuance of coverage under a health benefit plan if the cancellation or discontinuance of coverage: (i) has only a prospective effect; or(ii) is effective retroactively to the extent it is attributable to a failure to timely pay required premiums or contributions toward the cost of coverage.Utah Admin. Code R590-261-3
Amended by Utah State Bulletin Number 2023-10, effective 5/9/2023